Company Overview and News

 
Fixed maturity plans back in vogue as bond yields on the rise

2018-03-07 moneycontrol
Fixed Maturity Plans or FMPs are back in the game in a big way with new fund offers from 10 mutual fund houses already on, and many more set for launch in the days to come.
Upvote Downvote

 
MFs had a terrific run in 2017, but can they create wealth for investors in 2018?

2017-12-29 moneycontrol
After a fantastic year for Indian equity markets, domestic mutual fund industry experts are hoping for another blockbuster year in 2018.
Upvote Downvote

 
Maturity of Mutual Fund Scheme of Kotak Mahindra Mutual Fund.

2017-10-10 indiainfoline
By clicking on submit button, you authorize IIFL & its representatives & agents to provide information about various products, offers and services provided by IIFL through any mode including telephone calls, SMS, letters etc. . you confirm that laws in relation to unsolicited communication referred in “National Do Not Call Registry” as laid down by “Telecom Regulatory Authority of India” will not be applicable for such information/ communication.
Upvote Downvote

 
What fall in Infosys stock means for Mutual fund houses

2017-08-18 moneycontrol
Vishal Sikka, resigned from his post of MD & CEO of Infosys effective today. The stock was the top loser on both S&P BSE Sensex and Nifty.
Upvote Downvote

 
RBI may need to drain up to $22 billion as inflows add to excess liquidity

2017-08-10 in.reuters
MUMBAI (Reuters) - The Reserve Bank of India (RBI) will likely have to drain up to $22 billion in excess liquidity from the financial system as surging foreign investments forces the central bank to absorb the dollar inflows and sell rupees to cap gains in the local currency.
Upvote Downvote

 
Suspension of trading in the Units of Mutual Fund Scheme of Kotak Mahindra Mutual Fund.

2017-06-14 indiainfoline
Trading Members of the Exchange are hereby informed that, Kotak Mahindra Asset Management Ltd. has informed and requested that trading in units of the following schemes are not available for trading on the Exchange pursuant to the record date of June 16,2017 fixed for the purpose of determining unit holders.
Upvote Downvote

 
Sebi asks MFs to explain promoter group exposure to AUMs

2017-04-16 moneycontrol
Markets regulator Sebi has asked several mutual fund houses to explain the rise in fund inflows from promoter group entities and associates to their overall assets under management.
Upvote Downvote

 
MF news : Multi Asset Allocation Fund features revised by Kotak Mahindra MF

2017-03-05 indiainfoline
Kotak Mahindra Mutual Fund has revised the features of Kotak Multi Asset Allocation Fund, with effect from Apr 12.
Upvote Downvote

 
How top funds voted in big corporate decisions

2017-02-24 thehindubusinessline
Four of the country’s biggest funds chose to abstain from voting on Maruti Suzuki’s contentious related-party transaction with its Japanese parent in December 2015, voting disclosures by the fund houses show. Similarly, in the case of Vedanta-Cairn merger, four of the top five mutual fund firms voted for it despite concerns around the use of cash on Cairn’s books.
Upvote Downvote

 
Maturity of Mutual Fund Scheme of Kotak Mahindra Mutual Fund.

2017-02-17 indiainfoline
Trading Members of the Exchange are hereby informed that, Kotak Mahindra Asset Management Company Ltd. has now informed and requested the Exchange to ensure that the units of the below mentioned scheme are not available for trading on the Exchange pursuant to Record date of 20th February 2017 fixed for maturity of the said Mutual Fund Scheme.
Upvote Downvote

 
Maturity of Mutual Fund Scheme of Kotak Mahindra Mutual Fund.

2017-02-09 indiainfoline
Trading Members of the Exchange are hereby informed that, Kotak Mahindra Asset Management Company Ltd. has now informed and requested the Exchange to ensure that the units of the below mentioned scheme are not available for trading on the Exchange pursuant to Record date of 13th February 2017 fixed for maturity of the said Mutual Fund Scheme.
Upvote Downvote

 
Kotak MF trims earnings growth to single-digits for FY17

2016-12-20 moneycontrol
Demonetisation will dent corporate profits for this quarter and the next, and a recovery is likely only in FY18, says Shibani Sircar Kurian Senior Vice President & Head -Equity Research, Kotak Mahindra Mutual Fund
Upvote Downvote

 
Re-Listing of units of Kotak FMP Series 131 a scheme under Kotak Mahindra Mutual Fund after rollover

2016-11-30 indiainfoline
Re-Listing of units of Kotak FMP Series 131 a scheme under Kotak Mahindra Mutual Fund after rollover
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...